Furosemide
- Product NDC
- 17224-185
- 11-digit product format
- 172240185
- Labeler code
- 17224
- Product ID
- 17224-185_166340cd-364a-14fd-e063-6294a90a03b4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FUROSEMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Calvin Scott & Co., Inc.
- Application
- ANDA077293
- Marketing category
- ANDA
- Marketing start
- 2006-02-01
- Substance
- FUROSEMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Furosemide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FUROSEMIDE | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7LXU5N7ZO5 |
| Rxcui | 313988 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17224-185-21 | Furosemide | 21 in 1 BOTTLE, PLASTIC | TABLET | 21 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17224-185 | FUROSEMIDE (FUROSEMIDE) TABLET [CALVIN SCOTT & CO., INC.] | 1 | Current NDC, 1 package rows | 20240425_b2cc89e5-6619-4113-ad31-48076652c856.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 17224-185-21 | 17224018521 | 21 TABLET in 1 BOTTLE, PLASTIC (17224-185-21) | 21 tablet | 2016-05-15 | No | No | Current |